Evaluation of CYP17A1 and LEP Gene Polymorphisms in Breast Cancer

KARAKUŞ N., Kara N., Ulusoy A. N., Ozaslan C., Tural Ş., OKAN İ.

ONCOLOGY RESEARCH AND TREATMENT, cilt.38, sa.9, ss.418-422, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 9
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1159/000438940
  • Dergi Adı: ONCOLOGY RESEARCH AND TREATMENT
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.418-422
  • Anahtar Kelimeler: Breast cancer, Leptin, CYP17A1, Genetic susceptibility, Polymorphism, LIFE-STYLE FACTORS, RISK, ESTROGEN, PROMOTER
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Background: Polymorphisms of estrogen synthesis- and adiposity-related genes can contribute to the development of breast cancer. The purpose of the current study was to analyze the association between CYP17A1 T27C (rs743572) and LEP -2548G>A (rs7799039) gene polymorphisms and breast cancer. Material and Methods: 199 breast cancer patients and 197 healthy controls were included in the study. The CYP17A1 and LEP gene polymorphisms were determined using polymerase chain reaction-based restriction fragment length polymorphism analysis. Results: No statistically significant association was found between these polymorphisms and breast cancer risk among a Turkish population. However, stratified analysis of these polymorphisms in relation to different clinicopathological characteristics of breast cancer revealed an association between breast cancer diagnosis and the CYP17A1 T27C polymorphism (p = 0.024). Conclusion: Our study suggests no strong association between the CYP17A1 T27C and LEP -2548G>A polymorphisms and the incidence of breast cancer in Turkish women. The potential association between CYP17A1 T27C and the type of breast cancer deserves further consideration. (C) 2015 S. Karger GmbH, Freiburg